Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567
出版年份 2013 全文链接
标题
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 170, Issue 3, Pages 624-640
出版商
Wiley
发表日期
2013-08-14
DOI
10.1111/bph.12314
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
- (2014) Johan Söderlund et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists
- (2013) Michael A. Letavic et al. ACS Medicinal Chemistry Letters
- The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
- (2012) Masaaki Iwata et al. BRAIN BEHAVIOR AND IMMUNITY
- The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain
- (2012) Rómeó D. Andó et al. BRAIN RESEARCH BULLETIN
- P2X7 Receptors: Channels, Pores and More
- (2012) C. Volonte et al. CNS & Neurological Disorders-Drug Targets
- The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice
- (2012) Cecilia Csölle et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of CE-224,535, an Antagonist of P2X7 Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate
- (2012) T. C. STOCK et al. JOURNAL OF RHEUMATOLOGY
- The role of the innate immune system in psychiatric disorders
- (2012) Kenneth A. Jones et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Molecular mechanism of ATP binding and ion channel activation in P2X receptors
- (2012) Motoyuki Hattori et al. NATURE
- Neuromodulation by Extracellular ATP and P2X Receptors in the CNS
- (2012) Baljit S. Khakh et al. NEURON
- Inflammation in neurological and psychiatric diseases
- (2012) Parto S. Khansari et al. INFLAMMOPHARMACOLOGY
- P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts
- (2011) Pia Soronen et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535
- (2011) Allen J. Duplantier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder
- (2011) Lena Backlund et al. BIPOLAR DISORDERS
- Guide to Receptors and Channels (GRAC), 5th edition
- (2011) SPH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Physiology, Pharmacology and Future of P2X7 as An Analgesic Drug Target: Hype or Promise?
- (2011) Anindya Bhattacharya et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Adenosine and ATP Receptors in the Brain
- (2011) Geoffrey Burnstock et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice
- (2011) Tobias Engel et al. FASEB JOURNAL
- In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases
- (2011) Juan Ignacio Diaz-Hernandez et al. NEUROBIOLOGY OF AGING
- Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test
- (2011) A.A. Boucher et al. NEUROSCIENCE
- Activation and Regulation of Purinergic P2X Receptor Channels
- (2011) C. Coddou et al. PHARMACOLOGICAL REVIEWS
- Purinergic signalling: From normal behaviour to pathological brain function
- (2011) Geoffrey Burnstock et al. PROGRESS IN NEUROBIOLOGY
- Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays
- (2010) Steven J Charlton et al. BRITISH JOURNAL OF PHARMACOLOGY
- Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat
- (2010) SL Able et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor
- (2010) Anna K. Clark et al. GLIA
- P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways
- (2010) Miho Shiratori et al. JOURNAL OF NEUROCHEMISTRY
- New structure enlivens interest in P2X receptors
- (2010) Liam E. Browne et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?
- (2009) Elaine K. Green et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Variation inP2RX7candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples
- (2009) Maria Grigoroiu-Serbanescu et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Mechanism of action of species-selective P2X7 receptor antagonists
- (2009) Anton D Michel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
- (2009) Diana L Donnelly-Roberts et al. BRITISH JOURNAL OF PHARMACOLOGY
- A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder
- (2009) Rushaniya A. Khairova et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antagonists of the P2X7Receptor. From Lead Identification to Drug Development
- (2009) Simon D. Guile et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peripheral origin of IL-1β production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X7 receptors
- (2009) C. Csölle et al. JOURNAL OF NEUROIMMUNOLOGY
- Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
- (2009) J S Rao et al. MOLECULAR PSYCHIATRY
- Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory
- (2009) Ja Wook Koo et al. NEUROSCIENCE LETTERS
- Association between depression and the Gln460Arg polymorphism of P2RX7 Gene: A dimensional approach
- (2008) Krisztina Hejjas et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Signaling at Purinergic P2X Receptors
- (2008) Annmarie Surprenant et al. Annual Review of Physiology
- Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders
- (2008) Ana M. Basso et al. BEHAVIOURAL BRAIN RESEARCH
- P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
- (2008) Anthony J Sharp et al. Journal of Neuroinflammation
- Case–control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders
- (2008) A McQuillin et al. MOLECULAR PSYCHIATRY
- Purinergic signalling and disorders of the central nervous system
- (2008) Geoffrey Burnstock NATURE REVIEWS DRUG DISCOVERY
- [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors
- (2008) Diana L. Donnelly-Roberts et al. NEUROPHARMACOLOGY
- IL-1 is an essential mediator of the antineurogenic and anhedonic effects of stress
- (2008) J. W. Koo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Purinergic signalling in the nervous system: an overview
- (2008) Maria P. Abbracchio et al. TRENDS IN NEUROSCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started